Pediatrix Medical Group, Inc. (NYSE:MD) Shares Acquired by Prudential Financial Inc.

Prudential Financial Inc. raised its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 6.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 808,658 shares of the company's stock after acquiring an additional 46,635 shares during the quarter. Prudential Financial Inc. owned approximately 0.94% of Pediatrix Medical Group worth $10,610,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Quest Partners LLC grew its position in shares of Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company's stock valued at $35,000 after purchasing an additional 622 shares during the last quarter. Everence Capital Management Inc. grew its holdings in Pediatrix Medical Group by 7.5% during the 4th quarter. Everence Capital Management Inc. now owns 13,840 shares of the company's stock valued at $182,000 after buying an additional 960 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock valued at $51,000 after buying an additional 1,040 shares during the last quarter. Quarry LP increased its position in Pediatrix Medical Group by 54.1% during the third quarter. Quarry LP now owns 4,735 shares of the company's stock worth $55,000 after buying an additional 1,662 shares in the last quarter. Finally, AlphaQuest LLC lifted its position in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after acquiring an additional 2,012 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company's stock.

Wall Street Analysts Forecast Growth

MD has been the subject of a number of recent research reports. Macquarie initiated coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an "outperform" rating and a $18.00 price objective for the company. Truist Financial boosted their price objective on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a "hold" rating in a research report on Friday, February 21st. StockNews.com upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Finally, UBS Group boosted their price target on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a "neutral" rating in a report on Friday, February 21st. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $17.08.

Pediatrix Medical Group Trading Up 0.9 %

Shares of MD traded up $0.13 during mid-day trading on Wednesday, reaching $14.64. The company had a trading volume of 75,855 shares, compared to its average volume of 627,977. Pediatrix Medical Group, Inc. has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The stock has a market cap of $1.26 billion, a price-to-earnings ratio of -12.20, a price-to-earnings-growth ratio of 1.74 and a beta of 1.49. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The firm has a fifty day simple moving average of $14.42 and a 200-day simple moving average of $13.74.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $502.36 million during the quarter, compared to the consensus estimate of $486.22 million. On average, sell-side analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.